A novel antidiabetic drug, troglitazone - Reason for hope and concern

被引：41

作者：

Imura, H ^{[1
]}

机构：

[1] Kyoto Univ, Kyoto 6068501, Japan

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1998年 / 338卷 / 13期

关键词：

D O I：

10.1056/NEJM199803263381311

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：908 / 909

页数：2

共 9 条

[1] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients [J].

Auboeuf, D ;

Rieusset, J ;

Fajas, L ;

Vallier, P ;

Frering, V ;

Riou, JP ;

Staels, P ;

Auwerx, J ;

Laville, M ;

Vidal, H .

DIABETES, 1997, 46 (08) :1319-1327

[2] 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].

FORMAN, BM ;

TONTONOZ, P ;

CHEN, J ;

BRUN, RP ;

SPIEGELMAN, BM ;

EVANS, RM .

CELL, 1995, 83 (05) :803-812

[3] REDUCTION OF INSULIN RESISTANCE IN OBESE AND OR DIABETIC ANIMALS BY 5-[4-(1-METHYLCYCLOHEXYLMETHOXY)BENZYL]-THIAZOLIDINE-2,4-DIONE (ADD-3878, U-63,287, CIGLITAZONE), A NEW ANTI-DIABETIC AGENT [J].

FUJITA, T ;

SUGIYAMA, Y ;

TAKETOMI, S ;

SOHDA, T ;

KAWAMATSU, Y ;

IWATSUKA, H ;

SUZUOKI, Z .

DIABETES, 1983, 32 (09) :804-810

[4] CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].

FUJIWARA, T ;

YOSHIOKA, S ;

YOSHIOKA, T ;

USHIYAMA, I ;

HORIKOSHI, H .

DIABETES, 1988, 37 (11) :1549-1558

[5] Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus [J].

Inzucchi, SE ;

Maggs, DG ;

Spollett, GR ;

Page, SL ;

Rife, FS ;

Walton, V ;

Shulman, GI .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :867-872

[6] Effects of troglitazone - A new hypoglycemic agents in patients with NIDDM poorly controlled by diet therapy [J].

Iwamoto, Y ;

Kosaka, K ;

Kuzuya, T ;

Akanuma, Y ;

Shigeta, Y ;

Kaneko, T .

DIABETES CARE, 1996, 19 (02) :151-156

[7] Effect of troglitazone in insulin-treated patients with type II diabetes mellitus [J].

Schwartz, S ;

Raskin, P ;

Fonseca, V ;

Graveline, JF .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :861-866

[8] Troglitazone [J].

Spencer, CM ;

Markham, A .

DRUGS, 1997, 54 (01) :89-101

[9] Hepatic dysfunction associated with troglitazone [J].

Watkins, PB ;

Whitcomb, RW .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (13) :916-917

← 1 →